A Double Blind Evaluation of the Antihypertensive Effect of Reserpine, Phenobarbital, Hydralazine, Syrosingopine, and Placebo in Ambulatory Subjects
Authors:
- 1 October 1960
- journal article
- research article
- Published by SAGE Publications in Angiology
- Vol. 11 (5) , 381-386
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Effect of Rauwolfa serpentina and Reserpine on the Blood Pressure in Essential HypertensionCirculation, 1957
- Technic of Controlled Drug AssayNew England Journal of Medicine, 1957
- A COMPARISON OF THE EFFECTS OF PHENOBARBITONE AND RESERPINE IN HYPERTENSIONThe Lancet, 1957
- RESERPINE AS AN ANTIHYPERTENSIVE IN THE OUTPATIENT CLINIC: A DOUBLE-BLIND CLINICAL STUDYThe American Journal of the Medical Sciences, 1956
- RESERPINE-HYDRALAZINE COMBINATION THERAPY OF HYPERTENSIVE DISEASE, WITH HYDRALAZINE IN DOSES GENERALLY BELOW THE "TOXIC RANGE"Annals of Internal Medicine, 1956
- Treatment of Hypertension With Reserpine (Serpasil) Alone and in Combination with Hydralazine (Apresoline)Angiology, 1955
- TREATMENT OF HYPERTENSION WITH ORAL RESERPINE ALONE AND IN COMBINATION WITH HYDRALAZINE OR HEXAMETHONIUMThe American Journal of the Medical Sciences, 1955
- How to evaluate a new drugThe American Journal of Medicine, 1954
- Renal and hypotensive effects of acute and chronic oral treatment with 1-hydrazinophthalazine (apresoline) in hypertensionAmerican Heart Journal, 1954
- Renal Hyperemia Induced in Man by a New Phthalazine DerivativeExperimental Biology and Medicine, 1950